Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Osteoprotegerin and adynamic bone disease].

J J Kazama1

  • 1Niigata University Graduate School of Medical and Dental Science.

Clinical Calcium
|March 19, 2005
PubMed
Summary

High levels of osteoprotegerin (OPG) in dialysis patients contribute to adynamic bone disease by inhibiting bone resorption. This effect is more pronounced in older patients, exacerbating skeletal resistance to parathyroid hormone (PTH).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between evacuation and becoming overweight after the Great East Japan Earthquake: a 7-year follow-up of the Fukushima Health Management Survey.

Public health·2024
Same author

Cumulative incidence of femoral localized periosteal thickening (beaking) preceding atypical femoral fractures in patients with rheumatoid arthritis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Patients undergoing dialysis therapy for 30 years or more survive with serious osteoarticular disorders.

Clinical nephrology·2008
Same author

The making of a bone in blood vessels: from the soft shell to the hard bone.

Kidney international·2007

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Biology

Context:

  • Adynamic bone disease (ABD) is a common complication in dialysis patients.
  • Skeletal resistance to parathyroid hormone (PTH) is a key factor in ABD pathogenesis.
  • Osteoclastogenesis and activation research has advanced understanding of bone diseases.

Purpose:

  • To investigate the role of serum osteoprotegerin (OPG) in the development of ABD in dialysis patients.
  • To explore the relationship between OPG levels, glomerular filtration rate, and bone resorption parameters.
  • To determine if aging influences OPG levels and skeletal resistance to PTH in dialysis patients.

Summary:

  • Serum OPG levels increase with declining glomerular filtration rate in dialysis patients.
  • Elevated OPG levels demonstrate in vitro osteoclastogenesis inhibitory action.
  • Bone resorption parameters negatively correlate with serum OPG levels in dialysis patients.
  • Serum OPG concentration increases with aging, even in dialysis patients, potentially worsening skeletal resistance to PTH and contributing to ABD prevalence in older individuals.

Impact:

  • Circulating OPG in uremic patients may promote ABD development via osteoclastogenesis inhibition.
  • Findings highlight OPG as a potential therapeutic target for managing bone disease in dialysis patients.
  • Understanding OPG's role can lead to improved management strategies for ABD in aging populations.

Related Experiment Videos